Milestone Pharmaceuticals Inc.
MIST· Nasdaq
MISTMilestone Pharmaceuticals Inc.
Filed Nov 12, 2021 · 10-Q · 43 days after period end · 0001558370-21-015629
| Metric | Q3 2021 | Q3 2020 | Q3 2019 | Q3 2018 |
|---|---|---|---|---|
| Net Income | -$14.23M | -$11.98M | -$12.83M | -$5.70M |
| EPS Diluted | -$0.34 | -$0.40 | -$0.52 | -$20.16 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Milestone Pharmaceuticals Inc. · CIK 1408443 · Engraved from SEC EDGAR
ended Sep 30, 2021 · filed Nov 12, 2021 · 43 d after period end
